STI
22
-5
SRE
61
2
CMG
44
-6
MAC
27
-2
MSFT
48
-5
M
37
-8
SE
69
-6
MCK
63
-3
EMN
49
-4
UNM
52
-5
KMB
44
8
AZO
56
-2
PH
62
-8
QCOM
57
-7
CCI
44
2
PSX
37
-7
VTR
50
-2
SPG
48
-7
APD
47
-3
RF
51
-9
STI
22
-5
SRE
61
2
CMG
44
-6
MAC
27
-2
MSFT
48
-5
M
37
-8
SE
69
-6
MCK
63
-3
EMN
49
-4
UNM
52
-5
KMB
44
8
AZO
56
-2
PH
62
-8
QCOM
57
-7
CCI
44
2
PSX
37
-7
VTR
50
-2
SPG
48
-7
APD
47
-3
RF
51
-9
Financhill
Back

Smith & Nephew PLC Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
41

SNN
Smith & Nephew PLC

Last Price:
$26.30
Seasonality Move:
-1.36%
Sell
38

SRPT
Sarepta Therapeutics

Last Price:
$105.55
Seasonality Move:
5.14%
Sell
41
Smith & Nephew PLC (SNN) is a Sell

Is Smith & Nephew PLC a Buy, Sell or Hold?

  • The current Smith & Nephew PLC [SNN] share price is $26.13. The Score for SNN is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • SNN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $106.12. The Score for SRPT is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SNN Stock Price Chart

What is Smith & Nephew PLC's stock price today?

  • The Smith & Nephew PLC share price today is $26.13
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SNN is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $106.12
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

SNN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.2 Buy
Relative Strength Index (14 RSI): 59.89 Buy
Chaikin Money Flow: 382039 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (25.07 - 25.81) Buy
Bollinger Bands (100): (24.22 - 28.08) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.32 Sell
Relative Strength Index (14 RSI): 35.13 Sell
Chaikin Money Flow: -665542 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (109.06 - 117.26) Sell
Bollinger Bands (100): (113.14 - 127.52) Sell

SNN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 25.67 Buy
20-day SMA: 25.48 Buy
50-day SMA: 25.12 Buy
200-day SMA: 27.05 Sell
8-day EMA: 25.71 Buy
20-day EMA: 25.48 Buy
50-day EMA: 25.46 Buy
200-day EMA: 26.56 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 107.99 Sell
20-day SMA: 112.1 Sell
50-day SMA: 118.2 Sell
200-day SMA: 128.11 Sell
8-day EMA: 108.31 Sell
20-day EMA: 111.56 Sell
50-day EMA: 116.18 Sell
200-day EMA: 122.74 Sell

Smith & Nephew PLC Earnings Growth & SNN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.24 per share, and a decrease next year of $0.03 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.70 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.63 per share, and an increase next year of $4.84 per share.

Smith & Nephew PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):